FABP5 and gastric cancer: Thus, to test this hypothesis, we knocked down FABP5 and NME1 in seven different gastric cancer cell lines, including AGS, HGC-27, MGC-803, KATO III, NCI-N87, SNU-5, and SNU-16 (Figs. 5C and S5B–D).